Skip to content

Twitter page opens in new window Linkedin page opens in new window Instagram page opens in new window

info@pharmaust.com+61 8 9202 6814

PharmAust (PAA)

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

Daily Archives: January 15, 2019

Monepantel Metabolite Shows Anticancer Activity

News & Announcements 2019By Richard Mollard January 15, 2019

190115_metabolite

Recent Articles

Epichem Corporate Presentation July 2020
July 2, 2020
PharmAust Shareholder Update Presentation June 2020
July 2, 2020
June 30, Top 20 Shareholders
July 1, 2020
JP Equity Partners – Broker Analyst Report – July 2020
June 30, 2020

MENU

Home
About Us
Pipeline & Trials
Investor Centre
Media
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Leave this field empty if you're human:

TWITTER

PharmAustFollow

Retweet on Twitter PharmAust Retweeted

Epichem @epichem·

Do you need more certainty around the structure of your #molecule of interest? Epichem can help you through the power of X-ray #crystallography!

Contact us for how our formula can assist in your success:
👉 sales@epichem.com.au
or go to https://bit.ly/2TpBdbo

#chemistry

Reply on Twitter 1280303040491372544 Retweet on Twitter 12803030404913725441 Like on Twitter 12803030404913725447 Twitter 1280303040491372544

Copyright © 2020 Pharmaust. All rights reserved.

Website Design & Digital Marketing Perth by Total Click Solutions